Literature DB >> 8098663

Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks.

F Martínez1, J Castillo, J R Rodríguez, R Leira, M Noya.   

Abstract

A current hypothesis for migraine suggests that neuroexcitatory amino acids may participate in the triggering of attacks. To investigate this possibility we measured glutamic and aspartic acid level in plasma and cerebrospinal fluid (CSF) of patients with common and classic migraine during attacks, making comparisons with controls suffering stress. Plasma levels of amino acids in migraine patients were lower than in controls. CSF concentrations of glutamic acid were higher in migraineurs than in controls. Our results suggest an excess of neuroexcitatory amino acids in the CNS of migraine patients during attacks, possibly favoring a state of neuronal hyperexcitability.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098663     DOI: 10.1046/j.1468-2982.1993.1302089.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  23 in total

Review 1.  Spectrum of complicated migraine in children: A common profile in aid to clinical diagnosis.

Authors:  Surya N Gupta; Vikash S Gupta; Dawn M Fields
Journal:  World J Clin Pediatr       Date:  2015-02-08

Review 2.  Capillary endothelial Na(+), K(+), ATPase transporter homeostasis and a new theory for migraine pathophysiology.

Authors:  Michael G Harrington; Alfred N Fonteh; Xianghong Arakaki; Robert P Cowan; Laurel E Ecke; Hailey Foster; Andreas F Hühmer; Roger G Biringer
Journal:  Headache       Date:  2009-10-21       Impact factor: 5.887

3.  Association between salt substitutes/enhancers and changes in sodium levels in fast-food restaurants: a cross-sectional analysis.

Authors:  Mary J Scourboutakos; Sarah A Murphy; Mary R L'Abbé
Journal:  CMAJ Open       Date:  2018-03-07

Review 4.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

5.  Genome-wide association analysis identifies susceptibility loci for migraine without aura.

Authors:  Tobias Freilinger; Verneri Anttila; Boukje de Vries; Rainer Malik; Mikko Kallela; Gisela M Terwindt; Patricia Pozo-Rosich; Bendik Winsvold; Dale R Nyholt; Willebrordus P J van Oosterhout; Ville Artto; Unda Todt; Eija Hämäläinen; Jèssica Fernández-Morales; Mark A Louter; Mari A Kaunisto; Jean Schoenen; Olli Raitakari; Terho Lehtimäki; Marta Vila-Pueyo; Hartmut Göbel; Erich Wichmann; Cèlia Sintas; Andre G Uitterlinden; Albert Hofman; Fernando Rivadeneira; Axel Heinze; Erling Tronvik; Cornelia M van Duijn; Jaakko Kaprio; Bru Cormand; Maija Wessman; Rune R Frants; Thomas Meitinger; Bertram Müller-Myhsok; John-Anker Zwart; Markus Färkkilä; Alfons Macaya; Michel D Ferrari; Christian Kubisch; Aarno Palotie; Martin Dichgans; Arn M J M van den Maagdenberg
Journal:  Nat Genet       Date:  2012-06-10       Impact factor: 38.330

Review 6.  Glutamate and Its Receptors as Therapeutic Targets for Migraine.

Authors:  Jan Hoffmann; Andrew Charles
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 7.  Migraine is a neuronal disease.

Authors:  J Tajti; A Párdutz; E Vámos; B Tuka; A Kuris; Zs Bohár; A Fejes; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2010-12-15       Impact factor: 3.575

8.  Association between migraine and a functional polymorphism at the dopamine beta-hydroxylase locus.

Authors:  F Fernandez; N Colson; S Quinlan; J MacMillan; R A Lea; L R Griffiths
Journal:  Neurogenetics       Date:  2009-02-14       Impact factor: 2.660

Review 9.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

10.  Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period.

Authors:  Bernadett Tuka; Aliz Nyári; Edina Katalin Cseh; Tamás Körtési; Dániel Veréb; Ferenc Tömösi; Gábor Kecskeméti; Tamás Janáky; János Tajti; László Vécsei
Journal:  J Headache Pain       Date:  2021-06-25       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.